All Pharma News
ASCO 2024: Alligator shares positive data for pancreatic cancer drug

ASCO 2024: Alligator shares positive data for pancreatic cancer drug
Akosua Mireku PHARMACEUTICAL TECHNOLOGY
04 Jun 2024
Share Share
Alligator and Aptevo Announce Positive Data of Dose Escalation Ph of ALG.APV-527

Alligator and Aptevo Announce Positive Data of Dose Escalation Ph of ALG.APV-527
ACCESSWIRE
07 Mar 2024
Share Share
First-line Mitazalimab Plus Chemo Continues to Generate Responses in PDAC

First-line Mitazalimab Plus Chemo Continues to Generate Responses in PDAC
ONCOLIVE
27 Jun 2023
Share Share
Alligator & Aptevo Announce Dosing of First Patient with ALG.APV-527 in PI Trial

Alligator & Aptevo Announce Dosing of First Patient with ALG.APV-527 in PI Trial
ACCESSWIRE
13 Feb 2023
Share Share
Orion & Alligator reveal second stage of immuno-oncology research collaboration

Orion & Alligator reveal second stage of immuno-oncology research collaboration
John Pinching PHARMA TIMES
03 Jan 2023
Share Share
Alligator Announces +ve Interim Results from Mitazalimab OPTIMIZE-1 Ph 2 Trial

Alligator Announces +ve Interim Results from Mitazalimab OPTIMIZE-1 Ph 2 Trial
PIPELINEREVIEW
02 Jan 2023
Share Share
Alligator Bioscience & Aptevo Announce Publication Highlighting ALG.APV-527 s

Alligator Bioscience & Aptevo Announce Publication Highlighting ALG.APV-527 s
ACCESSWIRE
09 Nov 2022
Share Share
Alligator Announces IND Approval for Second Phase 2 Clinical Trial of AC101

Alligator Announces IND Approval for Second Phase 2 Clinical Trial of AC101
PRESS RELEASE
08 Nov 2022
Share Share
Alligator Bioscience announces positive safety data from ATOR-1017 study

Alligator Bioscience announces positive safety data from ATOR-1017 study
PHARMATIMES
30 Sep 2022
Share Share
Alligator Bioscience and Aptevo Therapeutics Announce that FDA has Issued

Alligator Bioscience and Aptevo Therapeutics Announce that FDA has Issued
ACCESSWIRE
19 Sep 2022
Share Share